Ethylene Glycol Residual Content Assessment Protocol: Standards, Testing Methods, and Applications

Ethylene glycol residue assessment is a critical quality, safety, and regulatory compliance control for pharmaceuticals, polymeric materials, food-contact packaging, and medical devices. This article presents a complete ethylene glycol residual content evaluation protocol, covering applicable regulatory limits, sample types, validated analytical methods such as headspace GC-FID and GC-MS, and practical industry applications. Use this guide to design a scientifically sound testing strategy and ensure your products meet global residual solvent and migration requirements.

Technical Overview

Ethylene glycol (EG, ethane-1,2-diol; CAS 107-21-1; molecular formula C2H6O2; molecular weight 62.07 g/mol) is a colorless, odorless, hygroscopic diol that is fully miscible with water and lower alcohols and boils at approximately 197 °C. It is widely used as a monomer in the synthesis of polyethylene terephthalate (PET) and unsaturated polyesters, as a process solvent and coupling agent in pharmaceutical and coating manufacture, as a humectant intermediate, and as a base fluid for heat transfer and antifreeze formulations. Because EG can remain in finished materials as unreacted monomer, trapped process solvent, or migration-derived contaminant, its residual level must be quantitatively assessed.

The toxicological concern is well established: absorbed ethylene glycol is metabolized via alcohol dehydrogenase to glycoaldehyde, glycolic acid, and oxalic acid, producing metabolic acidosis, central nervous system depression, and dose-dependent renal injury associated with calcium oxalate crystal deposition. Regulatory frameworks therefore impose strict limits. ICH Q3C classifies ethylene glycol as a Class 2 residual solvent with a permitted daily exposure (PDE) of 6.2 mg/day, corresponding to a 620 ppm concentration limit under Option 1; USP General Chapter <467> and Ph. Eur. 2.4.24 adopt equivalent controls for pharmaceutical articles. For food-contact plastics, EU Regulation 10/2011 and the Chinese standard GB 9685-2016 specify a specific migration limit (SML) of 30 mg/kg food simulant. For medical devices, ISO 10993-18 chemical characterization studies quantify extractable ethylene glycol to support toxicological risk assessment under ISO 10993-17.

This assessment protocol defines the complete analytical workflow: representative sampling, matrix-appropriate sample preparation, validated chromatographic quantitation, comparison against product-specific and regulatory acceptance criteria, and defensible reporting suitable for regulatory submissions, batch release, and investigations.

Testing Samples

Pharmaceutical Substances, Excipients, and Drug Products

Active pharmaceutical ingredients processed with ethylene glycol, excipients such as glycerin and propylene glycol that carry known risks of diethylene glycol or ethylene glycol adulteration, and finished dosage forms including tablets, granules, softgel capsules, and liquid formulations. Testing verifies compliance with ICH Q3C and pharmacopeial residual solvent requirements and supports batch release and stability programs.

Polymer Resins, Packaging, and Textiles

Bottle-grade and film-grade PET resins, preforms, bottles, polyester films and fibers, polyurethane components, and alkyd resin coatings. Residual ethylene glycol in PET typically arises from incomplete polycondensation or inadequate drying, and its level serves as an indicator of polymerization completeness and process consistency.

Medical Devices

Catheters, tubing sets, dialysis components, wound dressings, polyurethane parts, and device adhesives in which ethylene glycol may be present as a residual monomer, catalyst carrier, or process aid. Results feed into extractables and leachables (E&L) studies and ISO 10993-18 chemical characterization reports.

Food Contact Materials and Food Simulants

Packaging laminates, coatings, and articles intended for food contact, together with migration study samples generated in aqueous, acidic, alcoholic, and fatty food simulants per EU 10/2011 and corresponding national food contact regulations.

Cosmetics and Personal Care Products

Glycerin-based creams, lotions, toothpastes, and other formulations where ethylene glycol contamination of glycerin or propylene glycol supply chains must be excluded or quantified against internal safety thresholds.

Industrial Materials and Consumer Goods

Coatings, adhesives, printing inks, textiles, e-liquids, deodorant and heat transfer fluids, and miscellaneous products requiring cross-contamination checks, supplier verification, or failure analysis.

Testing Items

The protocol typically encompasses the following measurable attributes, selected according to the product type and regulatory driver:

• Residual ethylene glycol content in the article itself, reported in mg/kg (ppm) or percentage by weight.
• Migration of ethylene glycol into food simulants or extraction media, reported in mg/kg or mg/dm² against the applicable SML.
• Related glycol impurities, including diethylene glycol (CAS 111-46-6) and triethylene glycol (CAS 112-27-6), which frequently co-occur and share toxicological significance.
• Total glycol content for process monitoring purposes in polymer manufacturing.
• Semi-quantitative extractables screening in which ethylene glycol is one target among a broader E&L scope.
• Method validation attributes: specificity and separation from DEG/TEG, linearity and range, accuracy and recovery, repeatability and intermediate precision, limit of detection (LOD), limit of quantitation (LOQ), robustness, and solution stability.

Testing Methods

Gas chromatography is the reference platform for ethylene glycol quantitation because the analyte is sufficiently volatile, responds linearly on a flame ionization detector, and is cleanly resolved from related glycols on polar stationary phases. The high boiling point and strong polarity of ethylene glycol, however, demand deliberate sample preparation and, for trace-level work, derivatization or mass-selective detection.

Sample Preparation Strategies

• Liquids and solutions: direct dilution in water, methanol, or a water-methanol mixture followed by filtration.
• Solid dosage forms and general solids: extraction with water or methanol, assisted by sonication or controlled heating, with recovery confirmed by spike studies.
• Polyesters such as PET: dissolution in hexafluoroisopropanol (HFIP) or a phenol/tetrachloroethane mixture, followed by polymer precipitation and analysis of the supernatant; alternatively, elevated-temperature solvent extraction with validated extraction efficiency.
• Headspace sampling: equilibration at 80-105 °C for 30-45 minutes for matrices where direct injection is impractical, noting that reduced sensitivity must be compensated with optimized conditions.
• Derivatization: silylation with BSTFA containing 1% TMCS converts ethylene glycol to its bis-TMS ether, markedly improving chromatographic behavior and enabling sub-ppm LOQs.
• Internal standardization: 1,3-propanediol or 1,4-butanediol is added before preparation to correct for preparation and injection variability.

Instrumental Techniques

• Headspace GC-FID: robust and automated for routine ppm-level screening of residual ethylene glycol in compliant matrices.
• Direct-injection GC-FID on a polyethylene glycol (wax-type) capillary column, e.g., DB-WAX or equivalent: the workhorse quantitative method, routinely achieving LOQs of approximately 5-10 ppm and baseline resolution of EG from DEG and TEG with resolution not less than 1.5.
• GC-MS in selected ion monitoring mode using characteristic ions at m/z 31, 45, and 62: the confirmatory and high-sensitivity technique, capable of sub-ppm LOQs and unambiguous identification in complex or extracted matrices.
• HPLC with refractive index detection: an orthogonal option for matrices where gas chromatographic sample introduction is unsuitable, at the cost of somewhat higher LOQs.

Quantitation, Acceptance Criteria, and Quality Control

Quantitation is performed by multipoint internal or external standard calibration across a range bracketing the specification, with correlation coefficients of r² ≥ 0.999 expected for regulatory work. Results are compared against the applicable acceptance criteria: 620 ppm for pharmaceutical products under ICH Q3C Option 1 (or a product-specific limit derived from the PDE of 6.2 mg/day and maximum daily dose), 30 mg/kg for migration into food simulants under EU 10/2011 and GB 9685-2016, and client-defined or toxicologically derived limits for devices and cosmetics. Each analytical sequence incorporates reagent blanks, duplicate preparations, matrix spikes with recovery acceptance of 80-120%, and system suitability criteria including injection RSD ≤ 5% and peak tailing ≤ 2.0. The method is validated in accordance with ICH Q2(R2), and method transfer or verification is available for in-house laboratory adoption. A typical validated LOQ for ethylene glycol in polymer and pharmaceutical matrices falls in the range of 1-10 ppm, with LOD around one third of the LOQ.

Applications

• Incoming and release testing of bottle-grade PET resin, preforms, and containers to confirm residual glycol levels and polymerization completeness.
• Pharmaceutical batch release, registration stability studies, and regulatory dossier support demonstrating compliance with ICH Q3C, USP <467>, and Ph. Eur. 2.4.24.
• Supplier qualification and pharmacopeial verification of glycerin and propylene glycol to exclude ethylene glycol and diethylene glycol adulteration.
• ISO 10993-18 chemical characterization and E&L studies for medical devices submitted to regulatory authorities worldwide.
• Food contact compliance packages, including migration testing in simulants, for EU 10/2011, GB 9685, FDA food contact notifications, and customer specifications.
• Investigations of out-of-specification results, consumer complaints, and contamination events, including root cause analysis and batch comparability assessment.
• Process development support, such as optimizing drying, devolatilization, and polycondensation endpoints, and evaluating residue trends over storage and shipping conditions.

FAQ

What is the regulatory limit for residual ethylene glycol?

For pharmaceuticals, ICH Q3C assigns ethylene glycol to Class 2 with a PDE of 6.2 mg/day, equivalent to 620 ppm under Option 1; product-specific limits may be lower depending on the maximum daily dose. For food-contact plastics, the SML is 30 mg/kg in food simulants under EU 10/2011 and GB 9685-2016. Medical devices and cosmetics use toxicologically derived or internal safety thresholds, and client specifications always take precedence when stricter.

Can ethylene glycol be separated from diethylene glycol and triethylene glycol?

Yes. Polar wax-type capillary GC columns provide baseline separation of ethylene glycol, diethylene glycol, and triethylene glycol, and GC-MS confirmation removes any residual ambiguity. All three glycols are routinely reported together, since they share sources and toxicological relevance.

What sample preparation is used for PET and other polyesters?

Polyester samples are typically dissolved in HFIP or a phenol/tetrachloroethane mixture at controlled temperature, after which the polymer is precipitated and the recovered solvent phase is analyzed by GC-FID or GC-MS. Alternatively, validated heated solvent extraction can be applied; extraction efficiency is always demonstrated through spiked recovery studies.

What detection capability can be expected?

Validated LOQs generally fall between 1 and 10 ppm depending on matrix and technique, with GC-MS in SIM mode reaching sub-ppm levels after derivatization. Reporting limits are always established well below the applicable regulatory limit to ensure meaningful compliance decisions.

How much sample is required and what is the turnaround time?

A typical submission requires 5-25 g of solid or 10-25 mL of liquid per sample, retained in sealed containers to prevent moisture exchange and volatile loss. Standard turnaround is 7-10 business days after sample receipt, with expedited services available for investigations and urgent release decisions.

Is the testing suitable for GMP and regulatory submission purposes?

Yes. Methods are developed and validated under ICH Q2(R2) with documented specificity, linearity, accuracy, precision, LOD/LOQ, robustness, and solution stability, and are executed within a quality system supporting data integrity. Complete validation packages, method transfer protocols, and expert interpretation reports are provided for regulatory submissions and audits.